相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A phase II study of Givinostat in combination with hydroxycarbamide in patients with polycythaemia vera unresponsive to hydroxycarbamide monotherapy
Guido Finazzi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2013)
A Phase I Study of Quisinostat (JNJ-26481585), an Oral Hydroxamate Histone Deacetylase Inhibitor with Evidence of Target Modulation and Antitumor Activity, in Patients with Advanced Solid Tumors
Balaji Venugopal et al.
CLINICAL CANCER RESEARCH (2013)
Effects of treatment with histone deacetylase inhibitors in solid tumors: a review based on 30 clinical trials
Tianzhu Qiu et al.
FUTURE ONCOLOGY (2013)
Integrated Genomic Analysis of the 8q24 Amplification in Endometrial Cancers Identifies ATAD2 as Essential to MYC-Dependent Cancers
Maria B. Raeder et al.
PLOS ONE (2013)
Effectiveness of the Histone Deacetylase Inhibitor (S)-2 against LNCaP and PC3 Human Prostate Cancer Cells
Anna Laurenzana et al.
PLOS ONE (2013)
Nuclear Myosin 1c Facilitates the Chromatin Modifications Required to Activate rRNA Gene Transcription and Cell Cycle Progression
Aishe Sarshad et al.
PLOS GENETICS (2013)
Phase I study of the histone deacetylase inhibitor entinostat in combination with 13-cis retinoic acid in patients with solid tumours
R. Pili et al.
BRITISH JOURNAL OF CANCER (2012)
The MEK1/2 inhibitor, selumetinib (AZD6244; ARRY-142886), enhances anti-tumour efficacy when combined with conventional chemotherapeutic agents in human tumour xenograft models
S. V. Holt et al.
BRITISH JOURNAL OF CANCER (2012)
Anticancer Drugs Aimed at E6 and E7 Activity in HPV-Positive Cervical Cancer
S. Tan et al.
CURRENT CANCER DRUG TARGETS (2012)
Combination of Valproic Acid and ATRA Restores RARβ2 Expression and Induces Differentiation in Cervical Cancer through the PI3K/Akt Pathway
D. Feng et al.
CURRENT MOLECULAR MEDICINE (2012)
Mesodermal retinoic acid signaling regulates endothelial cell coalescence in caudal pharyngeal arch artery vasculogenesis
Peng Li et al.
DEVELOPMENTAL BIOLOGY (2012)
Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance
Roel H. Wilting et al.
DRUG RESISTANCE UPDATES (2012)
Acetylation of H2A.Z is a key epigenetic modification associated with gene deregulation and epigenetic remodeling in cancer
Fatima Valdes-Mora et al.
GENOME RESEARCH (2012)
Significance of E-cadherin, β-catenin, and vimentin expression as postoperative prognosis indicators in cervical squamous cell carcinoma
Yong Cheng et al.
HUMAN PATHOLOGY (2012)
Cellular senescence and tumor suppressor gene p16
Hani Rayess et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Plakoglobin-dependent regulation of keratinocyte apoptosis by Rnd3
Katie R. Ryan et al.
JOURNAL OF CELL SCIENCE (2012)
Valproic acid induces differentiation and transient tumor regression, but spares leukemia-initiating activity in mouse models of APL
M. Leiva et al.
LEUKEMIA (2012)
Role of Histone Deacetylases in Gene Regulation at Nuclear Lamina
Beatrice C. Milon et al.
PLOS ONE (2012)
Altered expression of cell-cell adhesion molecules β-catenin/E-cadherin and related Wnt-signaling pathway in sporadic and syndromal keratocystic odontogenic tumors
Samer George Hakim et al.
CLINICAL ORAL INVESTIGATIONS (2011)
E-Cadherin/beta-Catenin Complex and the Epithelial Barrier
Xinrui Tian et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2011)
Interobserver variability of laryngeal mucosal premalignant lesions: a histopathological evaluation
Stijn A. J. H. M. Fleskens et al.
MODERN PATHOLOGY (2011)
Inactivating mutations of acetyltransferase genes in B-cell lymphoma
Laura Pasqualucci et al.
NATURE (2011)
Promoter Methylation of E-Cadherin, p16, and RAR-beta(2) Genes in Breast Tumors and Dietary Intake of Nutrients Important in One-Carbon Metabolism
Meng-Hua Tao et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2011)
Global Reactivation of Epigenetically Silenced Genes in Prostate Cancer
Ilsiya Ibragimova et al.
CANCER PREVENTION RESEARCH (2010)
Interactive Roles of Ets-1, Sp1, and Acetylated Histones in the Retinoic Acid-dependent Activation of Guanylyl Cyclase/Atrial Natriuretic Peptide Receptor-A Gene Transcription
Prerna Kumar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Reduced Aquaporin3 Expression and Survival of Keratinocytes in the Depigmented Epidermis of Vitiligo
Nan-Hyung Kim et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
Upregulation of vimentin and aberrant expression of E-cadherin/β-catenin complex in oral squamous cell carcinomas: correlation with the clinicopathological features and patient outcome
Lai-Kui Liu et al.
MODERN PATHOLOGY (2010)
Epigenetic targets in human neoplasms
Tamer E. Fandy et al.
EPIGENOMICS (2010)
Acyclic retinoid synergises with valproic acid to inhibit growth in human hepatocellular carcinoma cells
Hideharu Tatebe et al.
CANCER LETTERS (2009)
Genomic Antagonism between Retinoic Acid and Estrogen Signaling in Breast Cancer
Sujun Hua et al.
CELL (2009)
Studies on Multifunctional Effect of All-Trans Retinoic Acid (ATRA) on Matrix Metalloproteinase-2 (MMP-2) and Its Regulatory Molecules in Human Breast Cancer Cells (MCF-7)
Anindita Dutta et al.
JOURNAL OF ONCOLOGY (2009)
Expression-based screening identifies the combination of histone deacetylase inhibitors and retinoids for neuroblastoma differentiation
Cynthia K. Hahn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Histone deacetylase inhibitors: molecular mechanisms of action
W. S. Xu et al.
ONCOGENE (2007)
Epigenetic patterns of the retinoic acid receptor β2 promoter in retinoic acid-resistant thyroid cancer cells
A. Cras et al.
ONCOGENE (2007)
Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors
Thaddeus T. Schug et al.
CELL (2007)
Histone deacetylase inhibitor Trichostatin A induces global and gene-specific DNA demethylation in human cancer cell lines
Jing-Ni Ou et al.
BIOCHEMICAL PHARMACOLOGY (2007)
Up-regulation of HLA class-I antigen expression and antigen-specific CTL response in cervical cancer cells by the demethylating agent hydralazine and the histone deacetylase inhibitor valproic acid
Maria de Lourdes Mora-Garcia et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2006)
Sequential valproic acid/all-trans retinoic acid treatment reprograms differentiation in refractory and high-risk acute myeloid leukemia
Giuseppe Cimino et al.
CANCER RESEARCH (2006)
Molecular requirements for epithelial-mesenchymal transition during tumor progression
MA Huber et al.
CURRENT OPINION IN CELL BIOLOGY (2005)
Phosphoinositide 3-kinase signaling to Akt promotes keratinocyte differentiation versus death
E Calautti et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Histone acetylation and histone deacetylase activity of magnesium valproate in tumor and peripheral blood of patients with cervical cancer. A phase I study
Alma Chavez-Blanco et al.
MOLECULAR CANCER (2005)
Retinoic acid and the histone deacetylase inhibitor trichostatin A inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model
SE Touma et al.
CLINICAL CANCER RESEARCH (2005)
Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivo
F Fazi et al.
ONCOGENE (2005)
Retinoic acid and retinoid receptors: potential chemopreventive and therapeutic role in cervical cancer
J Abu et al.
LANCET ONCOLOGY (2005)
Histone deacetylation of RB-responsive promoters: Requisite for specific gene repression but dispensable for cell cycle inhibition
H Siddiqui et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Valproic acid induces apoptosis in human leukemia cells by stimulating both caspase-dependent and -independent apoptotic signaling pathways
R Kawagoe et al.
LEUKEMIA RESEARCH (2002)
分享论文
